| Pharmaceutical active ingredients: |
| Clonixin Lysine |
| Available forms, composition and doses of Firac: |
| Injectable; Injection; Clonixin Lysine 50 mg / mlTablets; Oral; Clonixin Lysine 125 mgTablets; Oral; Clonixin Lysine 250 mg |
| Firac medical category: |
| Human:Nonsteroidal anti-inflammatory drugs (NSAIDs) |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| ATCICD-10 |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Grossman Laboratorios |